Outcome measures following sonodynamic photodynamic therapy - A case series

Current Drug Therapy

Volumn 6, Issue 1, 2011, Pages 12-16

  Kenyon, Julian Norman ^a   Fuller, Richard James ^a  

^a The Dove Clinic for Integrated Medicine   (United Kingdom)

Author keywords

Cancer; Immunoediting; Photodynamic therapy; Sonodynamic therapy; Ultrasound

Indexed keywords

ASCORBIC ACID; PHOTOSENSITIZING AGENT; SONNELUX 1; TAMOXIFEN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; CASE REPORT; CONTROLLED STUDY; COUGHING; ENDOMETRIUM POLYP; HUMAN; IMMUNE RESPONSE; METASTASIS; NONHUMAN; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SONODYNAMIC PHOTODYNAMIC THERAPY; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUMOR CELL;

EID: 78650933000     PISSN: 15748855     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488511794079059     Document Type: Article

References (47)

1. Dougherty TJ, Lawrence G, Kaufman JH, Boyle D, Weishaupt KR, Goldfarb A. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 1979; 62: 231-7.
2. Biel MA. Photodynamic Therapy and the treatment of head and neck neoplasia. Laryngoscope 1998; 108: 1259-68.
3. Morton CA, Whitehurst C, McColl JH, Moore JV, MacKie RM. Photodynamic therapy for large or multiple patches of bowen disease and basal cell carcinoma. Arch Dermatol 2001; 137: 319-24.
4. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with topical 5-aminolae-vulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994; 69: 605-8.
5. McCaughan JS, Jr; Williams TE, Jr; Bethel, BH. Photodynamic therapy of endobronchial tumors. Lasers Surg Med 1986; 6: 336-45.
6. Zheng H. A review of progress in clinical photodynamic. Ther Technol Cancer Res Treat 2005; 4(3): 283-93.
7. Roberts WG, Hasan T. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Cancer Research I993; 53: 153-7.
8. Rosenthal I, Sostaric JZ, Riesz P. Sonodynamic therapy--a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 2004; 11: 349-63.
9. Umemura S, Yumita N, Nishifaki R, Umemura K. Sonochemical activation of hematoporphyrin: a potential modality for cancer treatment. IEEE Ultrason Symp1989; 9: 955.
10. Tachibana K, Kimura N, Okumura M, Eguchi H, Tachibana S. Enhancement of cell killing of HL-60 cells by ultrasound in the presence of the photosensitizing drug Photofrin II. Cancer Lett 1993; 72: 195.
11. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin Pharmacother 2001; 2(6): 917-27.
12. Ziskin MC. Fundamental physics of ultrasound and its propagation in tissue. Radio Graphics 1993; 13: 705-709.
13. Edmonds PD, Sancier KM. Evidence for free radical production by ultrasonic cavitation in biological media. Ultrasound Med Biol 1983; 9: 635-9.
14. Pilla AA, Figueiredo M, Nasser P, et al. Non-invasive low intensity pulsed ultrasound: a potent accelerator of bone repair. Proceedings, 36th Annual Meeting, Orthopaedics Research Society, New Orleans, 1990.
15. White P, Hynynen K, Clement G. Longitudinal and shear mode ultrasound propagation in human skull bone. Proc 5th meeting Internat Soc Ther Ultrasound 2005; 251.
16. Speed CA. Therapeutic ultrasound in soft tissue lesions. Rheumatology 2001; 40: 1331-6.
17. Jin, Z, Miyoshi N, Ishiguro K, et al. Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinoma in C3H/HeN mice. J Dermatol 2000; 27(5): 294-306.
18. Kuroki M, Hachimine K, Abe H, et al. Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Research 2007; 27(6A): 3673-7.
19. Hiller R, Putterman SJ, Barber BP. Spectrum of synchronous pico-seconds sonoluminescence. Phys Rev Lett 1992; 69: 1182-4.
20. Liu Q, Wang, Wang P, Xiao L, Hao Q. Comparison between sonodynamic effect with protoporphyrin IX and hematoporphyrin on sarcoma 180. Cancer Chemother Pharmacol 2007; 60: 671-80.
21. Wang X, Lewis T, Mitchell D. The tumoricidal effect of sonody-namic therapy (SDT) on S-180 sarcoma in mice. Integr Cancer Ther 2008; 7: 96-102.
22. Lewis T. Toxicity and cytopathogenic properties toward human melanoma cells of activated cancer therapeutics in Zebra fish. Integr Cancer Ther 2010; 9: 84-92.
23. Wang X, Zhang W, Xu Z, Luo Y, Mitchell D, Moss RW. Sonody-namic and photodynamic therapy in advanced breast carcinoma: A report of 3 cases. Integr Cancer Ther 2009; 8(3): 283-287.
24. Wang X, Lewis T. ASCO Annual Meeting Proceedings. J Clin Oncol Post-Meeting Ed 2008; 26: 12029.
25. Kenyon J, Fuller R, Lewis T. Activated cancer therapy using light and ultrasound - A Case series of sonodynamic photodynamic therapy in 115 patients over a 4 Year Period. Curr Drug Ther 2009; 4: 179-93.
26. Pages F, Berger A, Camus M. Effector memory T Cells, early metastasis and survival in colorectal cancer. N Engl J Med 2005; 353: 2654-66.
27. Sandeep S, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159-69.
28. Schumacher K, Haensch W, Röefzaad C, Schlag PM. Prognostic significance of activated CD8+ T Cell infiltrations within esophageal carcinomas. Cancer Res 2001; 61(10): 3932-6.
29. Sato E, Olson S, Ahn J, et al. Intraepithelial CD8+ tumour-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. PNAS 2005; 102(51): 18538-43.
30. Prestwich R, Errington F, Hatfield P, et al. The immune system - is it relevant to cancer development, progression and treatment? Clin Oncol 2008; 20(2): 101-12.
31. Demaria S, Bhardwaj N, McBride WH, Formenti SC. Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys 2005; 63: 655.
32. Lake RA, Robinson BW. Immunotherapy and chemotherapy a practical partnership. Nat Rev Cancer 2005; 5(5): 397-405.
33. Gollnick S, Brackett C. Enhancement of anti-tumor immunity by photodynamic therapy. Immunol Res 2010; 46: 216-26.
34. Matzinger P. The danger model: a renewed sense of self. Science 2002; 296: 301-305.
35. Castano AP, Mroz P, Hamblin MR Photodynamic therapy and antitumour immunity. Nat Rev Cancer 2006; 6: 535-45
36. Cecic I, Parkins CS, Korbelik M. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photo-chem Photobiol 2001; 74: 712-20.
37. Gollnick SO, Evans SE, Baumann H, et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 2003; 88: 1772-9.
38. Cecic I, Stott B, Korbelik M. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int Immunopharmacol 2006; 6: 1259-66.
39. Nseyo UO, Whalen RK, Duncan MR, Berman B, Lundahl SL. Urinary cytokines following photodynamic therapy for bladder cancer. Urology 1990; 36: 167-71.
40. Castano AP, Gad R, Zahra T, Hamblin MR. Specific anti-tumor immune response with photodynamic therapy mediated by ben-zoporphyrin derivative and chlorin(e6). Proc SPIE 2003; 4961: doi:10.1117/12.477654.
41. Kabingu E, Vaughan L, Owczarczak B, Ramsey KD, Gollnick SO. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4 T cells and dependent on natural killer cells. Br J Cancer 2007; 96(12): 1839-48.
42. Abdel-Hady ES, artin-Hirsch P, Duggan-Keen M, et al. Immu-nological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res 2001; 61: 192-6.
43. Thong PS, Ong KW, Goh NS, et al. Photodynamic-therapy- activated immune response against distant untreated tumours in recurrent angiosarcoma. Lancet Oncol 2007; 8: 950-2.
44. Xiaopeng M, Huixuan P, Jilin Y. Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment. Med Hypotheses 2009; 72(4): 418-20.
45. Hoogsteen IJ, Marres H, van der Kogel AJ, Kaanders J. The hypoxic tumour microenvironment, patient selection and hypoxiamodifying treatments. Clin Oncol (R Coll Radiol) 2007; 19(6): 385-96.
46. Clavo B, Pérez J, López L, et al. Ozone Therapy for tumor oxygenation: a Pilot Study. eCAM 2004; 1(1): 93-9. doi:10.1093/ ecam/neh009.
47. Castano AP, Mroz P, Wu M, Hamblin MR. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. PNAS 2008; 105(14): 5495-500.